Provided by Tiger Fintech (Singapore) Pte. Ltd.

Jaguar Animal Health

2.57
+0.07002.80%
Pre-market: 2.53-0.0400-1.56%05:53 EDT
Volume:104.93K
Turnover:267.30K
Market Cap:3.40M
PE:-0.02
High:2.60
Open:2.50
Low:2.50
Close:2.50
Loading ...

83.33% of Veterinary Oncologists Highlight Importance of Jaguar Health's FDA Conditionally Approved Canalevia-CA1 as a Non-Antibiotic Treatment for Chemotherapy-Induced Diarrhea (CID) in Dog's in New Survey

ACCESS Newswire
·
28 Mar

Jaguar Health Inc expected to post a loss of $18.50 a share - Earnings Preview

Reuters
·
28 Mar

Jaguar Health Meeting with FDA Regarding Results of Phase 3 OnTarget Study

ACCESS Newswire
·
27 Mar

Sector Update: Health Care Stocks Retreat Wednesday Afternoon

MT Newswires Live
·
27 Mar

Jaguar Health Presenting March 27 at Emerging Growth Conference and Holding Investor Webcast March 31 Regarding Q4 2024 Financials & Near-Term Catalysts

ACCESS Newswire
·
26 Mar

Jaguar Health Executives Invest in $3.5 Million Bridge Financing; Shares Fall

MT Newswires Live
·
26 Mar

Jaguar Health CEO, board members, investors invest in $3.448M bridge financing

TIPRANKS
·
26 Mar

Jaguar Health CEO, Board Members, Other C-Suite Members, and Institutional and Accredited Investors Invest in $3.448 Million Bridge Financing Priced At-The-Market Under Nasdaq Rules

ACCESS Newswire
·
26 Mar

Presenting on the Emerging Growth Conference 80 Day 2 on March 27 Register Now

GlobeNewswire
·
26 Mar

Jaguar Health to Implement 1-for-25 Reverse Stock Split

MT Newswires Live
·
18 Mar

Jaguar Health, Inc. Announces Reverse Stock Split

ACCESS Newswire
·
18 Mar

Jaguar Health adopts limited duration stockholder rights plan

TIPRANKS
·
27 Feb

Jaguar Health Adopts Limited Duration Stockholder Rights Plan to Ensure Stockholders Can Realize Long-Term Value

ACCESS Newswire
·
27 Feb

Jaguar Health extends collaboration with Streeterville to develop P-300

TIPRANKS
·
18 Feb

Jaguar Health-Extends Collaboration for Possible Tropical Disease Priority Review Voucher and Cholera Indication for Np-300

THOMSON REUTERS
·
18 Feb

Jaguar Health, Inc. (NASDAQ:JAGX) Might Not Be As Mispriced As It Looks After Plunging 30%

Simply Wall St.
·
06 Feb

Jaguar Health announces first SBS-IF patient dosed in IIT trial of crofelemer

TIPRANKS
·
03 Feb

Jaguar Health announces first patient dosed in IIT evaluating crofelemer

TIPRANKS
·
22 Jan